Proceeding contribution from Lord Patel (Crossbench) in the House of Lords on Tuesday, 4 December 2007. It occurred during Committee of the Whole House (HL) and Debate on bill on Human Fertilisation and Embryology Bill [HL].
Human Fertilisation and Embryology Bill [HL]
As I understand it the Bill will allow applications under regulation for a licence to create embryonic stem cell lines for research purposes. These research purposes include research on treatment but do not include creating embryonic stem cell lines specifically for therapy. My plea was that this is required to make clinical-grade stem cell lines—lines of a sufficiently quality high to have been produced under GMP facilities—available for use in treatment.
Secondary information
- Type
- Proceeding contribution
- Reference
- 696 c1637
- Session
- 2007-08
- Chamber / Committee
- House of Lords chamber
- Subjects
- Abortion Fertility Human embryo experiments Donors Human Fertilisation and Embryology Authority Ethics IVF NHS Medical treatments Parents Organs Medicine Standards Training Screening Regulation Research Stem cells Christianity
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 00:38:31 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_426936
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_426936
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_426936